Page last updated: 2024-08-23

paclitaxel and Adenoma, Hepatocellular

paclitaxel has been researched along with Adenoma, Hepatocellular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, HG; Choi, JY; Choi, Y; Kim, J; Kwang Ku, S; Oh Kim, J; Poudal, BK; Ramasamy, T; Ruttala, HB; Soon Yong, C1

Other Studies

1 other study(ies) available for paclitaxel and Adenoma, Hepatocellular

ArticleYear
Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.
    Oncotarget, 2017, Feb-28, Volume: 8, Issue:9

    Topics: Adenoma, Liver Cell; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lipids; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Paclitaxel; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays

2017